RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy

Por Flores-Pérez, Ali, Rafaelli, Lourdes E, Ramírez-Torres, Nayeli, Aréchaga-Ocampo, Elena, Frías, Sara, Sánchez, Silvia, Marchat, Laurence A, Hidalgo-Miranda, Alfredo, Quintanar-Jurado, Valeria, Rodríguez-Cuevas, Sergio, Bautista-Piña, Verónica, Carlos-Reyes, Ángeles, López-Camarillo, César
Publicado em 2014